4 Results for "

rat CYP3A

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "rat CYP3A" in MCE Product Catalog:

Cat. No.: HY-19400
CAS No.: 284661-68-3
Synonyms: DPH-153893
Research Areas:  

Infection

DPC-681 (DPH-153893) is an orally active HIV inhibitor. DPC-681 inhibits HIV protease activity and inhibits wild-type and mutant HIV replication. DPC-681 can be used for the research of HIV infection .
loading...
    loading...
Cat. No.: HY-107534
CAS No.: 263847-55-8
Purity:  99.52%
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

AG-045572 is a GnRH receptor antagonist with Kis of 6.0 nM and 3.8 nM for human and rat GnRH receptor, respectively. AG-045572 is metabolized by CYP3A and ressuppresses testosterone .
loading...
    loading...
Cat. No.: HY-114246
CAS No.: 1351185-54-0
Synonyms: ONC1-13B
Research Areas:  

Cancer

Varilutamide (ONC1-13B) is an orally active androgen receptor (AR) inhibitor. Varilutamide shows a rat AR IC50 of 7.9 μM, inhibits DHT-stimulated PSA expression and prostate cancer cell proliferation, suppresses tumor growth and PSA expression and weakly induces lower CYP3A activity. Varilutamide can be used for the research of castration-resistant prostate cancer and prostate cancer .
loading...
    loading...
Cat. No.: HY-W110138
CAS No.: 23833-97-8
Research Areas:  

Cancer

Chloroxoquinoline is an anticancer agent. Chloroxoquinoline damages the DNA templates of cancer cells, inducing DNA breaks and cell death, and inhibits cell invasion via down-regulating Rho/Rho kinase signaling pathway. Chloroxoquinoline enhances the radiation sensitivity of Lewis lung cancer cells and xenograft tumors in tumor-bearing mouse models but decreases efficacy after long term exposure in rat models by auto-induction effects on CYP1A and CYP3A. Chloroxoquinoline has a broad-spectrum anticancer activity, such as non-small-cell lung carcinoma (NSCLC), breast cancer and gastric cancer .
loading...
    loading...